Lin K, Nguyen B D, Ettinger D S, Chin B B
Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
Clin Nucl Med. 1999 Jan;24(1):24-8. doi: 10.1097/00003072-199901000-00006.
This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin.
In-111 pentetreotide (In-111 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma.
Subsequent treatment with nonradioactive somatostatin inhibited tumor growth.
In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.
